Zurich Cantonal Bank
RVMD icon

Zurich Cantonal Bank’s Revolution Medicines RVMD Stock Holding History

Zurich Cantonal Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,517
Closed -$3.63M – 3343
2025
Q4 		$3.63M Buy
+45,517
New +$2.98M 0.01% 715

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zurich Cantonal Bank's RVMD Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Revolution Medicines (RVMD) in Q1 2026: 68,018 shares worth $6.61M. The stake represents 0.01% of the portfolio and ranks #585 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in RVMD as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in RVMD in Q2 2021 and has held it in 19 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Zurich Cantonal Bank held 68,018 shares of Revolution Medicines worth $6.61M as of Q1 2026.
  • Revolution Medicines was a new Zurich Cantonal Bank position in Q1 2026.
  • Revolution Medicines made up 0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #585 holding.
  • Zurich Cantonal Bank first reported a position in Revolution Medicines in Q2 2021 and has held it in 19 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.